Jan van der Heyden
Overview
Explore the profile of Jan van der Heyden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donal E, Dreyfus J, Leurent G, Coisne A, Leroux P, Ganivet A, et al.
JAMA
. 2024 Nov;
333(2):124-132.
PMID: 39602173
Importance: Correction of tricuspid regurgitation using tricuspid transcatheter edge-to-edge repair (T-TEER) in addition to guideline-directed optimized medical therapy (OMT) may improve clinical outcomes. Objective: To evaluate the efficacy of T-TEER ...
2.
Ooms J, Cornelis K, Wijeysundera H, Vandeloo B, van der Heyden J, Kovac J, et al.
Clin Res Cardiol
. 2024 Apr;
PMID: 38619575
Background: Transcatheter aortic valve implantation (TAVI) serves a growing range of patients with severe aortic stenosis (AS). TAVI has evolved to a streamlined procedure minimizing length of hospital stay. Aims:...
3.
Dubois C, Adriaenssens T, Annemans L, Bosmans J, Callebaut B, Candolfi P, et al.
Acta Cardiol
. 2024 Mar;
79(1):46-57.
PMID: 38450496
Background: Transcatheter aortic valve implantation (TAVI) with the SAPIEN 3 device has recently shown significant clinical benefits, compared to surgical aortic valve replacement (SAVR), in patients at low risk for...
4.
Claeys M, Aminian A, Bartunek J, Bennett J, Buysschaert I, Claeys M, et al.
Catheter Cardiovasc Interv
. 2023 Dec;
103(2):382-388.
PMID: 38078877
Background: Evidence-based recommendations for antithrombotic treatment in patients who have an indication for oral anticoagulation (OAC) after transcatheter edge-to-edge mitral valve repair (TEER) are lacking. Aims: To compare bleeding and...
5.
Sorajja P, Gorgorishvili I, Burns M, Buysschaert I, Debonnaire P, van der Heyden J, et al.
EuroIntervention
. 2023 Jul;
19(8):662-663.
PMID: 37483101
No abstract available.
6.
Bouisset F, Sia J, Mizukami T, Karjalainen P, Tonino P, Pijls N, et al.
JAMA Cardiol
. 2023 May;
8(7):703-708.
PMID: 37203243
Importance: Titanium-nitride-oxide (TiNO)-coated stents show faster strut coverage compared with drug-eluting stents without excessive intimal-hyperplasia observed in bare metal stents. It is important to study long-term clinical outcomes after treatment...
7.
Baggio S, Pagnesi M, Kim W, Scotti A, Barbanti M, Costa G, et al.
EuroIntervention
. 2022 Sep;
18(12):977-986.
PMID: 36093795
Background: The ACURATE neo2 (NEO2) and Evolut PRO/PRO+ (PRO) bioprostheses are new-generation self-expanding valves developed for transcatheter aortic valve replacement (TAVR). Aims: We sought to compare the performance of the...
8.
Ooms J, Cornelis K, Stella P, Rensing B, van der Heyden J, Chan A, et al.
Cardiovasc Revasc Med
. 2022 Jun;
44:71-77.
PMID: 35739011
Background: Transcatheter aortic valve replacement (TAVR) is now an established treatment strategy for elderly patients with symptomatic aortic stenosis (AS) across the entire operative risk spectrum. Streamlined TAVR protocols along...
9.
Scotti A, Pagnesi M, Kim W, Schafer U, Barbanti M, Costa G, et al.
EuroIntervention
. 2022 Jun;
18(10):804-811.
PMID: 35678222
Background: Transcatheter aortic valve replacement (TAVR) with the ACURATE neo device has been associated with a non-negligible incidence of paravalvular aortic regurgitation (AR). The new-generation ACURATE neo2 has been designed...
10.
Buzzatti N, Taramasso M, Puri R, van der Heyden J
Front Cardiovasc Med
. 2022 May;
9:891914.
PMID: 35557536
No abstract available.